Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C11H11N2O2S.Cu |
| Molecular Weight | 298.828 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cu+].[O-]C(=O)C1=CC=CC(NC(=S)NCC=C)=C1
InChI
InChIKey=ZZDFYPGVZZDZBL-UHFFFAOYSA-M
InChI=1S/C11H12N2O2S.Cu/c1-2-6-12-11(16)13-9-5-3-4-8(7-9)10(14)15;/h2-5,7H,1,6H2,(H,14,15)(H2,12,13,16);/q;+1/p-1
| Molecular Formula | C11H11N2O2S |
| Molecular Weight | 235.282 |
| Charge | -1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | Cu |
| Molecular Weight | 63.546 |
| Charge | 1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13239940
Cuprelone (Allocupreide) has been tried in 100 mg doses intravenously twice weekly for a month.
Route of Administration:
Intravenous
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:58:10 GMT 2025
by
admin
on
Mon Mar 31 21:58:10 GMT 2025
|
| Record UNII |
ZH635E3D4S
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
73951933
Created by
admin on Mon Mar 31 21:58:10 GMT 2025 , Edited by admin on Mon Mar 31 21:58:10 GMT 2025
|
PRIMARY | |||
|
ZH635E3D4S
Created by
admin on Mon Mar 31 21:58:10 GMT 2025 , Edited by admin on Mon Mar 31 21:58:10 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |